Mereo BioPharma Group (MREO) Receivables Refunds: 2020-2025
Historic Receivables Refunds for Mereo BioPharma Group (MREO) over the last 2 years, with Sep 2025 value amounting to $520,000.
- Mereo BioPharma Group's Receivables Refunds rose 10.17% to $520,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $520,000, marking a year-over-year increase of 10.17%. This contributed to the annual value of $464,000 for FY2024, which is 22.54% down from last year.
- Mereo BioPharma Group's Receivables Refunds amounted to $520,000 in Q3 2025, which was up 4.84% from $496,000 recorded in Q2 2025.
- In the past 5 years, Mereo BioPharma Group's Receivables Refunds ranged from a high of $5.6 million in Q2 2021 and a low of $464,000 during Q4 2024.
- Moreover, its 3-year median value for Receivables Refunds was $501,000 (2025), whereas its average is $529,286.
- In the last 5 years, Mereo BioPharma Group's Receivables Refunds tumbled by 83.35% in 2022 and then rose by 10.17% in 2025.
- Over the past 5 years, Mereo BioPharma Group's Receivables Refunds (Quarterly) stood at $1.1 million in 2021, then plummeted by 83.35% to $931,892 in 2022, then reached $599,000 in 2023, then decreased by 22.54% to $464,000 in 2024, then climbed by 10.17% to $520,000 in 2025.
- Its last three reported values are $520,000 in Q3 2025, $496,000 for Q2 2025, and $501,000 during Q1 2025.